Поиск
Поиск
Автор: miller daisy. Gefitinib is a targeted therapy widely used for treating non-small cell lung cancer (NSCLC), particularly in patients with specific epidermal growth factor receptor (EGFR) mutations. As an EGFR tyrosine kinase inhibitor, Gefitinib blocks the signals that promote cancer cell growth, slowing tumor progression and improving patient outcomes. It is often prescribed as a first-line treatment for advanced or metastatic NSCLC, especially in individuals who test positive for EGFR mutations...
Изменен: 26.02.2025